Shunda Du: Clinical Trials

2 trials sponsored by Shunda Du, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Recruiting 2

Follow Shunda Du: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lenalidomide Plus Targeted Therapy and Immunotherapy for Refractory HCC
Lenalidomide, Targeted Therapy, Immune Checkpoint Inhibitors - Hepatocellular Carcinoma (HCC)
Phase 2RecruitingShunda Du322026-08-122026-09-21
Irreversible Electroporation Combined With Targeted Therapy and Immunotherapy for Advanced Hepatocellular Carcinoma
Irreversible Electroporation, Lenvatinib, Sintilimab - Hepatocellular Carcinoma (HCC)
Phase 2RecruitingShunda Du302025-04-012026-09-21

Conditions studied

Carcinoma, Hepatocellular (2)

Interventions

Electroporation (1)  ·  Immune Checkpoint Inhibitors (1)  ·  Lenalidomide (1)  ·  lenvatinib (1)  ·  sintilimab (1)

Countries

China (2)